Aprogen Biologics Inc. (KRX:003060)
South Korea · Delayed Price · Currency is KRW 540.00
-23.00 (-4.09%)
At close: Jan 30, 2026
Aprogen Biologics Market Cap
Aprogen Biologics has a market cap or net worth of 106.69 billion as of January 30, 2026. Its market cap has decreased by -17.05% in one year.
Market Cap
106.69B
Enterprise Value
322.72B
Revenue
74.91B
Ranking
n/a
PE Ratio
n/a
Stock Price
540.00
Market Cap Chart
Since January 5, 1996, Aprogen Biologics's market cap has increased from 3.18B to 106.69B, an increase of 3,254.41%. That is a compound annual growth rate of 12.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 106.69B | 4.05% |
| Dec 30, 2025 | 102.54B | -21.60% |
| Dec 30, 2024 | 130.79B | -31.41% |
| Dec 28, 2023 | 190.68B | -4.89% |
| Dec 29, 2022 | 200.48B | -44.42% |
| Dec 30, 2021 | 360.71B | -31.18% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Daihan Pharmaceutical | 168.76B |
| Whan In Pharm | 163.66B |
| SAMSUNG PHARM. Co., LTD. | 157.75B |
| Ilsung Is | 149.48B |
| HANDOK | 147.97B |
| Kyongbo Pharmaceutical | 143.92B |
| Ildong Holdings | 141.15B |
| Jeil Pharma Holdings | 122.96B |